Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "lung"

344 News Found

Manipal Hospital Delhi opens advanced cancer care centre
Hospitals | December 23, 2021

Manipal Hospital Delhi opens advanced cancer care centre

The hospital has recently launched Radionuclide therapy


A 39-year-old patient with Covid-19 was saved with ECMO support
Hospitals | December 22, 2021

A 39-year-old patient with Covid-19 was saved with ECMO support

Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital


Novartis collaborates with BeiGene to strengthen immunotherapy pipeline
Biotech | December 21, 2021

Novartis collaborates with BeiGene to strengthen immunotherapy pipeline

Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis


NMPA approves CStone's NDA for Cejemly
Drug Approval | December 21, 2021

NMPA approves CStone's NDA for Cejemly

The NMPA approval is based on the positive data of GEMSTONE-302 study, a multi-center, randomized, double-blind, phase III study that evaluated the efficacy and safety of Cejemly or placebo in combination with chemotherapy in first-line stage IV NSCLC patients


Prashanth Hospitals performs a rare open chest surgery
Hospitals | December 20, 2021

Prashanth Hospitals performs a rare open chest surgery

The surgery was helmed by Prof. Dr. Vishwanath Pai, Sr. Consultant, Department of Minimally Invasive Surgery, Prashanth Hospitals, Velachery


Merck’s tepmetko receives positive CHMP opinion in Europe
Biotech | December 20, 2021

Merck’s tepmetko receives positive CHMP opinion in Europe

The medicine is the first and only oral MET inhibitor to receive CHMP positive opinion in Europe for adult patients with advanced NSCLC harbouring alterations leading to METex14 skipping


Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
Biotech | December 13, 2021

Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia

It is a novel oral NLRP3 inflammasome inhibitor


Philips instals 1000 active cath labs in India
Medical Device | December 13, 2021

Philips instals 1000 active cath labs in India

Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities


Olympus lays out its plans for growth in the medical business
Digitisation | December 08, 2021

Olympus lays out its plans for growth in the medical business

Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected


Early management of Covid-19 key to reduce mortality and hospitalisation
Events | December 06, 2021

Early management of Covid-19 key to reduce mortality and hospitalisation

The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19